Insider Trading disclosures for Angiodynamic Inc

The latest disclosure was made by Warren G. Nighan in Angiodynamic Inc where a trade of 4,060 Common Stock done at an average price of $12.3 was reported to US exchanges on Jan. 16, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Warren G. Nighan	SVP Quality and Regulatory	Sale of securities on an exchange or to another person at price $ 12.31 per share.	16 Jan 2025	4,060	41,817 (0%)	0%	12.3	49,979	Common Stock
Stephen A. Trowbridge	EVP and CFO	Purchase of securities on an exchange or from another person at price $ 5.86 per share.	08 Oct 2024	1,700	172,711 (0%)	0%	5.9	9,962	Common Stock
James C. Clemmer	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 6.03 per share.	07 Oct 2024	20,000	681,582 (1%)	0%	6.0	120,600	Common Stock
Warren G. Nighan	SVP Quality and Regulatory	Purchase of securities on an exchange or from another person at price $ 6.08 per share.	07 Oct 2024	100	45,877 (0%)	0%	6.1	608	Common Stock
Warren G. Nighan	SVP Quality and Regulatory	Purchase of securities on an exchange or from another person at price $ 6.09 per share.	07 Oct 2024	768	45,777 (0%)	0%	6.1	4,677	Common Stock
James C. Clemmer	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share.	20 Jul 2024	2,982	637,405 (1%)	0%	7.1	21,262	Common Stock
James C. Clemmer	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share.	20 Jul 2024	3,372	634,033 (1%)	0%	7.1	24,042	Common Stock
Warren G. Nighan	SVP Quality and Regulatory	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share.	20 Jul 2024	277	40,998 (0%)	0%	7.1	1,975	Common Stock
Warren G. Nighan	SVP Quality and Regulatory	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share.	20 Jul 2024	251	41,275 (0%)	0%	7.1	1,790	Common Stock
Stephen A. Trowbridge	EVP and CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share.	20 Jul 2024	667	166,470 (0%)	0%	7.1	4,756	Common Stock
Stephen A. Trowbridge	EVP and CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share.	20 Jul 2024	717	167,137 (0%)	0%	7.1	5,112	Common Stock
Chad Thomas Campbell	SVP/GM, Vascular Access	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share.	20 Jul 2024	395	63,587 (0%)	0%	7.1	2,816	Common Stock
Chad Thomas Campbell	SVP/GM, Vascular Access	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share.	20 Jul 2024	359	63,982 (0%)	0%	7.1	2,560	Common Stock
Laura Piccinini	SVP International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share.	20 Jul 2024	413	38,052 (0%)	0%	7.1	2,945	Common Stock
Laura Piccinini	SVP International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share.	20 Jul 2024	616	38,465 (0%)	0%	7.1	4,392	Common Stock
James C. Clemmer	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share.	19 Jul 2024	8,307	636,570 (1%)	0%	7.2	59,644	Common Stock
Warren G. Nighan	SVP Quality and Regulatory	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share.	19 Jul 2024	735	41,526 (0%)	0%	7.2	5,277	Common Stock
Chad Thomas Campbell	SVP/GM, Vascular Access	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share.	19 Jul 2024	1,025	64,341 (0%)	0%	7.2	7,360	Common Stock
Laura Piccinini	SVP International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share.	19 Jul 2024	1,983	39,081 (0%)	0%	7.2	14,238	Common Stock
James C. Clemmer	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2024	7,466	7,466	-		-	Non-Qualified Stock Option (right to buy)
James C. Clemmer	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2024	7,633	7,633	-		-	Performance Right
James C. Clemmer	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2024	3,817	640,387 (1%)	0%		0	Common Stock
Eileen O'Shea Auen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	20,541	87,043 (0%)	0%		0	Common Stock
Howard W. Donnelly	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	20,541	149,376 (0%)	0%		0	Common Stock
Wesley E. Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	20,541	125,863 (0%)	0%		0	Common Stock
James C. Clemmer	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	207,693	207,693	-		-	Non-Qualified Stock Option (right to buy)
James C. Clemmer	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	211,622	211,622	-		-	Performance Right
James C. Clemmer	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	105,811	644,877 (1%)	0%		0	Common Stock
Warren G. Nighan	SVP Quality and Regulatory	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	23,952	23,952	-		-	Performance Right
Warren G. Nighan	SVP Quality and Regulatory	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	23,507	23,507	-		-	Non-Qualified Stock Option (right to buy)
Warren G. Nighan	SVP Quality and Regulatory	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	18,733	42,261 (0%)	0%		0	Common Stock
Stephen A. Trowbridge	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	76,458	76,458	-		-	Non-Qualified Stock Option (right to buy)
Stephen A. Trowbridge	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	77,905	77,905	-		-	Performance Right
Stephen A. Trowbridge	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	38,953	167,854 (0%)	0%		0	Common Stock
Jan Stern Reed	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	20,541	87,359 (0%)	0%		0	Common Stock
Michael E. Tarnoff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	20,541	65,703 (0%)	0%		0	Common Stock
Chad Thomas Campbell	SVP/GM, Vascular Access	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	12,350	65,366 (0%)	0%		0	Common Stock
Chad Thomas Campbell	SVP/GM, Vascular Access	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	24,240	24,240	-		-	Non-Qualified Stock Option (right to buy)
Chad Thomas Campbell	SVP/GM, Vascular Access	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	24,699	24,699	-		-	Performance Right
Karen A. Licitra	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	20,541	72,760 (0%)	0%		0	Common Stock
Lorinda A. Burgess	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	20,541	37,582 (0%)	0%		0	Common Stock
Laura Piccinini	SVP International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	21,971	41,064 (0%)	0%		0	Common Stock
Laura Piccinini	SVP International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	30,428	30,428	-		-	Performance Right
Laura Piccinini	SVP International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2024	29,863	29,863	-		-	Non-Qualified Stock Option (right to buy)
James C. Clemmer	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jul 2024	56,279	690,312 (1%)	0%		0	Common Stock
James C. Clemmer	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share.	17 Jul 2024	28,730	661,582 (1%)	0%	7.4	212,602	Common Stock
James C. Clemmer	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jul 2024	52,378	0	-		-	Performance Right
Warren G. Nighan	SVP Quality and Regulatory	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jul 2024	5,677	46,675 (0%)	0%		0	Common Stock
Warren G. Nighan	SVP Quality and Regulatory	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share.	17 Jul 2024	1,666	45,009 (0%)	0%	7.4	12,328	Common Stock
Warren G. Nighan	SVP Quality and Regulatory	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jul 2024	7,550	0	-		-	Performance Right

Showing 1 to 50 of 500 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

26.89% Fall from 52W High

Insider Trading disclosures for Angiodynamic Inc

The latest disclosure was made by Warren G. Nighan in Angiodynamic Inc where a trade of 4,060 Common Stock done at an average price of $12.3 was reported to US exchanges on Jan. 16, 2025.

Screeners based on Insider Trading and SAST parameters